Local News: Windthorst, TX 

 | 

Sign Up

 | 

Sign In

Advertisment

Lamivudine (generic), Epivir, Epivir-HBV

Lamivudine (generic), Epivir, Epivir-HBV Wire

Comprehensive News Feed for Lamivudine (generic), Epivir, Epivir-HBV.

Results 1 - 20 of 38 in Lamivudine (generic), Epivir, Epivir-HBV

  1. Statin and Diabetes Drug Show Activity against Hepatitis B Virus in Laboratory Studies

    Thursday Dec 3 | HIV and Hepatitis

    SUMMARY: Simvastatin , a medication used to lower blood cholesterol, had a synergistic effect against hepatitis B virus when combined with antiviral drugs in a laboratory study, researchers reported last month at the 60th Annual Meeting of the American Association for the Study of Liver Diseases in Boston.

    Comment?

    Related Topix: Zocor, Simvastatin (generic), Medicine, Medication, Avandia, Rosiglitazone (generic), University of Oklahoma, Viread, Tenofovir (generic), Tohoku, Japan, World News, Sendai, Japan, Japan

  2. Burcon announces appointment of a new director and patent grantsRead the original story

    Tuesday Dec 1 | Canada NewsWire

    D. Lorne Tyrrell to its board of directors. D. Lorne Tyrrell is the Canadian Institute of Health Research /Glaxo SmithKline Chair in Virology in the Department of Medical Microbiology and Immunology at the University of Alberta.

    Comment?

    Related Topix: Immunology, Biology, Science, Hepatitis, Medicine, Health, Medication

  3. Findings on viral rebound discourage quick drug switches in resource-limited settingsRead the original story

    Tuesday Dec 1 | Aidsmap

    A South African study found that viral resuppression occurred in 41% of people who continued taking the same antiretroviral drug regimen after experiencing a viral load increase on treatment.

    Comment?

    Related Topix: HIV/AIDS, Health

  4. Tenofovir (Viread) Produces Good HBV Suppression in Chronic Hepatitis ...

    Monday Nov 23 | HIV and Hepatitis

    Tenofovir Produces Good HBV Suppression in Chronic Hepatitis B Patients with Resistance to Adefovir SUMMARY: Nucleoside/nucleotide analogs are highly effective against HBV , but the virus can evolve to become resistant to the drugs, especially when used as monotherapy.

    Comment?

    Related Topix: Viread, Tenofovir (generic), Medicine, Medication

  5. Long-term Data Show Telbivudine (Tyzeka) Suppresses HBV Viral Load...

    Thursday Nov 19 | HIV and Hepatitis

    Long-term Data Show Telbivudine Suppresses HBV Viral Load and Leads to HBeAg Clearance in Chronic Hepatitis B Patients SUMMARY: At the 60th Annual Meeting of the American Association for the Study of Liver Diseases this month in Boston, researchers reported 4-year data from the GLOBE study, indicating that the nucleoside analog telbivudine ...

    Comment?

    Related Topix: Medicine, Medication

  6. Early HBsAg Decline Predicts Sustained Response to Pegylated...

    Monday Nov 16 | HIV and Hepatitis

    SUMMARY: Chronic hepatitis B patients who experience an early decrease in hepatitis B surface antigen starting before week 24 of therapy are more likely to achieve sustained response to pegylated interferon alfa-2a , according to an analysis presented at the 60th Annual Meeting of the American Association for the Study of Liver Diseases this month ...

    Comment?

    Related Topix: Medicine, Medication

  7. Review Finds Pegylated Interferon Is More Effective than Lamivudine...

    Monday Nov 16 | HIV and Hepatitis

    SUMMARY: A systemic review of clinical trials found that pegylated interferon was more effective than the oral antiviral drug lamivudine at achieving endpoints including hepatitis B virus DNA clearance and hepatitis B "e" antigen seroconversion, investigators reported at the 60th Annual Meeting of the American Association for the Study of Liver ...

    Comment?

    Related Topix: Medicine, Medication

  8. Alledged Fort Hood Shooter Left Behind an Old Bottle of Combivir

    Nov 13, 2009 | About.com

    In a shoe box filled with vitamins and prescription medications, the alledged Fort Hood shooter Major Nidal Malik Hasan had a bottle of the HIV medication Combivir .

    Comment?

    Related Topix: Medicine, Medication

  9. Tenofovir (Viread) Regimens Are Effective and Well-tolerated in...Read the original story

    Nov 5, 2009 | HIV and Hepatitis

    Tenofovir Regimens Are Effective and Well-tolerated in Chronic Hepatitis B Patients with Decompensated Liver Disease SUMMARY: The nucleotide analog tenofovir , especially when combined with emtricitabine -- the 2 drugs in the Truvada coformulation -- was well-tolerated and produced good hepatitis B virus suppression and hepatitis B "e" antigen loss ...

    Comment?

  10. BARACLUDE(R) (entecavir) Demonstrated Greater Antiviral Efficacy...Read the original story

    Nov 3, 2009 | Medical News Today

    BARACLUDE Demonstrated Greater Antiviral Efficacy Compared To Adefovir In New Study Of Chronic Hepatitis B Patients With Cirrhosis Main Category: Liver Disease / Hepatitis Article Date: 03 Nov 2009 - 4:00 PST Bristol-Myers Squibb today announced 48-week data from an ongoing study of chronic hepatitis B patients with decompensated cirrhosis, in ...

    Comment?

    Related Topix: Hepatitis, Medicine, Health, Biotech, Bristol Myers Squibb, Healthcare Industry, Porto Alegre, Brazil, World News, Rio Grande do Sul, Brazil, Brazil, Medication

  11. Tenofovir (Viread) Suppresses HBV Viral Load Long-term in HIV/HBV...

    Nov 2, 2009 | HIV and Hepatitis

    Tenofovir Suppresses HBV Viral Load Long-term in HIV/HBV Coinfected Patients, but Kidney Function May Decline SUMMARY: HIV/HBV coinfected individuals treated with agents that are dually active against both virus experience rapid suppression of hepatitis B virus , and about 15% of those taking tenofovir plus emtricitabine achieve hepatitis B "e" ...

    Comment?

    Related Topix: Viread, Tenofovir (generic), Medication, HIV/AIDS, Health, Hepatitis, Niederosterreich, Austria, World News, Austria, Vienna, Austria

  12. Entecavir (Baraclude) Demonstrates Greater Antiviral Activity than...Read the original story

    Nov 2, 2009 | HIV and Hepatitis

    Entecavir Demonstrates Greater Antiviral Activity than Adefovir in Hepatitis B Patients with Decompensated Liver Disease SUMMARY: Entecavir exhibited greater antiviral activity against hepatitis B virus than adefovir in patients with decompensated liver cirrhosis, and was associated with clinical benefits including improved survival, according to a ...

    Comment?

  13. Long-term Studies Show Tenofovir (Viread) Safety and Efficacy Is...Read the original story

    Nov 2, 2009 | HIV and Hepatitis

    Long-term Studies Show Tenofovir Safety and Efficacy Is Sustained at 3 Years in HBeAg Positive and Negative Hepatitis B Patients SUMMARY: Long-term follow-up data from 2 clinical trials show that tenofovir remained active against hepatitis B virus and was generally well-tolerated for up to 3 years, researchers reported this past weekend at the 60th ...

    Comment?

    Related Topix: Viread, Tenofovir (generic), Medicine, Hepatitis, Biotech, Gilead Sciences, Healthcare Industry, HIV/AIDS

  14. Hepatitis B Virus Genotypes E, F, G, and H Appear Responsive to Treatment with Interferon AlphaRead the original story w/Photo

    Oct 15, 2009 | HIV and Hepatitis

    Patients with hepatitis B virus genotypes E, F, G, and H appear to be sensitive to interferon alpha, as well as nucleoside/nucleotide analogs, although sustained virological response rates did not exceed 50%, according to a report in the October 2009 issue of the Journal of Medical Virology .

    Comment?

  15. Avexa Closes Trial of Experimental NRTI Apricitabine, Will Evaluate 24-week DataRead the original story

    Oct 8, 2009 | HIV and Hepatitis

    Avexa recently announced that it will close a Phase 3 study of its investigational nucleoside reverse transcriptase inhibitor candidate apricitabine, and will analyze 24-week data ahead of schedule.

    Comment?

    Related Topix: Australia, World News, Victoria, Australia, Melbourne, Australia, HIV/AIDS, Health

  16. Most Patients with Low Baseline HBV Viral Load Can Safely Discontinue ...

    Oct 8, 2009 | HIV and Hepatitis

    Most Patients with Low Baseline HBV Viral Load Can Safely Discontinue Lamivudine after Achieving Virological Suppression Most chronic hepatitis B patients with low pre-treatment HBV DNA levels with pre-treatment HBV DNA < 10 8 copies/mL. This difference in cumulative relapse rates between the 2 groups was statistically significant .

    Comment?

    Related Topix: Medicine, Medication, Hepatitis, Health

  17. Resistance to Hepatitis B Drugs is Common among HIV/HBV Coinfected...

    Sep 14, 2009 | HIV and Hepatitis

    The material posted on HIV and Hepatitis.com about the 49th ICAAC is not approved by the American Society for Microbiology Resistance to Hepatitis B Drugs is Common among HIV-HBV Coinfected Patients Receiving Lamivudine-containing ART without Tenofovir Resistance to the hepatitis B drugs adefovir , entecavir , and telbivudine is common among ...

    Comment?

    Related Topix: Medicine, Medication, Viread, Tenofovir (generic)

  18. Current management of Hep B before and after liver transplantation

    Sep 8, 2009 | GastroHep.com News

    The most recent issue of Liver Transplantation investigates current management of hepatitis B virus infection before and after liver transplantation.

    Comment?

    Related Topix: Hepatitis, Medicine, Health, Medication

  19. HIV-HBV Coinfected Patients Respond to Antiretroviral Therapy as well ...

    Sep 3, 2009 | HIV and Hepatitis

    HIV positive people coinfected with hepatitis B virus respond as well to combination antiretroviral therapy as individuals with HIV alone, but they are more likely to die due to non-AIDS-related causes, according to a study published in the September 10, 2009 issue of AIDS .

    Comment?

    Related Topix: Viread, Tenofovir (generic), Medicine, Medication

  20. Abacavir (Ziagen) Backbone Suppresses HIV as well as Tenofovir (Viread) in Uk Chic StudyRead the original story

    Aug 23, 2009 | HIV and Hepatitis

    Patients who used abacavir as part of their first combination antiretroviral regimen experienced early HIV suppression similar to that of patients taking tenofovir -- regardless of initial viral load -- and the groups had similar low rates of virological failure at 48 weeks, according to a recent British study.

    Comment?

    Related Topix: Viread, Tenofovir (generic), Medicine, Medication, Ziagen, Abacavir (generic), HIV/AIDS, Health